-
Belgian SME keeps Dutch at UPC Brussels LD as CFI president rejects Esko’s bid to switch case to English
Read more: Belgian SME keeps Dutch at UPC Brussels LD as CFI president rejects Esko’s bid to switch case to EnglishThe President of the UPC Court of First Instance has refused Esko Software’s push for English, keeping a Brussels patent fight in Dutch.
-
First U.S. SEP injunction since 2007 now unlikely: Wilus v. Askey & Samsung pretrial conference gets canceled on short notice
Read more: First U.S. SEP injunction since 2007 now unlikely: Wilus v. Askey & Samsung pretrial conference gets canceled on short noticeOn Tuesday, Judge Gilstrap first modified the time of a Wilus v. Askey & Samsung pretrial conference, and later in the day canceled it altogether. Some interesting motions are now unlikely ever to be adjudicated.
-
FedEx can fight another day in Qualcomm dispute, as Federal Circuit considers IPR real-parties-in-interest
Read more: FedEx can fight another day in Qualcomm dispute, as Federal Circuit considers IPR real-parties-in-interestThe USPTO withdrew its initial defense of the PTAB’s refusal of FedEx’s arguments around real parties in interest.
-
Merz wins UPC appeal as CoA overturns Paris LD denial and grants PI against Viatris generic in France
Read more: Merz wins UPC appeal as CoA overturns Paris LD denial and grants PI against Viatris generic in FranceThe UPC CoA has reversed the Paris LD’s refusal of interim relief and granted Merz a preliminary injunction against Viatris Santé’s fampridine generic in France.
-
UPC Munich LD clarifies res judicata in infringement context and says those negotiating with pool can’t rely on missing infringement notice
Read more: UPC Munich LD clarifies res judicata in infringement context and says those negotiating with pool can’t rely on missing infringement noticeThe Munich LD clarified that prior judgments do not bar new infringement actions where later-generation products introduce new features, confirmed accessory liability for entities enabling EU market access, and held that prior patent pool negotiations can substitute for a formal infringement notice.
-
Pfizer settles with three Vyndamax generic challengers mid-trial, extends exclusivity, presumably through pay-for-delay
Read more: Pfizer settles with three Vyndamax generic challengers mid-trial, extends exclusivity, presumably through pay-for-delayPfizer has quickly reached a settlement with Cipla, Hikma, and Dexcel during a five-day bench trial in Delaware, ending the dispute and extending its effective monopoly.
-
BREAKING: Huawei has 5G patent license deal with Tesla — inadvertent disclosure by InterDigital counsel at UK Supreme Court hearing
Read more: BREAKING: Huawei has 5G patent license deal with Tesla — inadvertent disclosure by InterDigital counsel at UK Supreme Court hearingInterDigital’s barrister has just uniquely identified the previously unknown Avanci 5G licensor who has a direct license deal in place with Tesla as “the single biggest licensor”.



